Alan Mendelsohn

A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis

Nicolino Ruperto, Daniel J. Lovell, Rubén Cuttica et al. · Arthritis & Rheumatism · 2007 · 411 citations

Medicine, Pediatrics, Pharmacotherapy +12

The effect of infliximab plus methotrexate on the modulation of inflammatory disease markers in juvenile idiopathic arthritis: analyses from a randomized, placebo-controlled trial

Sudha Visvanathan, Carrie Wagner, Joseph C. Marini et al. · Pediatric Rheumatology · 2010 · 28 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

The Effect of Tildrakizumab on Cardiometabolic Risk Factors in Psoriasis by Metabolic Syndrome Status: Post Hoc Analysis of Two Phase 3 Trials (ReSURFACE 1 and ReSURFACE 2)

Alan Menter, Nehal N. Mehta, Mark Lebwohl et al. · Journal of Drugs in Dermatology · 2020 · 22 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15

Dose escalation and associated costs in biologic treatment of psoriasis based on real-world data

Jerry Bagel, Brad Glick, Jashin J. Wu et al. · Journal of Medical Economics · 2021 · 11 citations · Full text

Medicine, Pharmacoeconomics, Pharmacotherapy +16